- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03837249
Self-Management of Sleep Among Older Adults
February 24, 2020 updated by: Raeann G LeBlanc, University of Massachusetts, Amherst
Self-Management of Sleep Among Older Adults Using Personal Monitoring: A Feasibility Study
The purpose of this study is to test the feasibility of older persons use of a personal sleep monitoring device(PSMD)to improve self-management of sleep.
Disrupted sleep occurs in up to 50% of persons over the age of 65 with chronic health conditions.
Impaired sleep negatively influences subjective and objective health outcomes.To improve their sleep, older adults with chronic health conditions could benefit from objective information, available through personal health monitoring devices, about their current and changing sleep patterns.
Based on this information, sleep self-management interventions can be individualized and shared, and associations between sleep and health changes may be better managed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Amherst, Massachusetts, United States, 01003
- University of Massachusetts
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 65 years or older
- Self-report difficulty sleeping
- Willingness to wear the PSMD for four weeks
- Cognitive abilities (Mini Cog of 5 or above).
Exclusion Criteria:
- Under the age of 65
- Presence of known sleep disorders
- Severe cognitive or neurosensory impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Passive Personal Sleep Monitoring
Wears personal sleep monitor but does not actively self-monitor (will have access to the sleep data and self-monitoring after 4 weeks).
|
Wearable Sleep Self-Monitoring Device (Actigraphy)
Other Names:
|
|
Active Comparator: Individual Personal Sleep Monitoring
Wears personal sleep monitor and actively self-monitoring sleep and using data to self-manage sleep.
|
Wearable Sleep Self-Monitoring Device (Actigraphy)
Other Names:
|
|
Active Comparator: Socially Supported Sleep Monitoring
Wears a personal sleep monitor, actively self-monitoring using sleep data to self-manage sleep and shares data for supportive self-management.
|
Wearable Sleep Self-Monitoring Device (Actigraphy)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Use of A Personal Sleep Monitoring Device (PSMD)
Time Frame: up to 4 weeks
|
Demonstrates use of Personal Sleep Self-Monitor through data downloads and self-report
|
up to 4 weeks
|
|
Changes in Sleep
Time Frame: Week 1 and Week 4
|
Demonstrated sleep changes indicated by change in BRCS NINR PROMIS SF V1 Sleep Disturbance Scale 6a (a 6 item, 5 point likert scale with higher scores reflecting more sleep disturbance and lower scores less.
|
Week 1 and Week 4
|
|
Changes in Health
Time Frame: Week 1 and Week 4
|
Demonstrated health changes indicated by change in BRCS NINR PROMIS Global Health Short Form Scale 10a (10 item, 5 point likert scale) with higher scores reflecting better health (3 items reverse scoring)
|
Week 1 and Week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Usability of PSMD
Time Frame: Week 2 and 4
|
Demonstrated through adapted System Usability Scale Scores (10 items, 5 point likert scale) with high agreement demonstrating higher levels of satisfaction using the device
|
Week 2 and 4
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Raeann G LeBlanc, PhD, DNP, University of Massachusetts, Amherst
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 4, 2019
Primary Completion (Actual)
August 30, 2019
Study Completion (Actual)
January 30, 2020
Study Registration Dates
First Submitted
January 24, 2019
First Submitted That Met QC Criteria
February 11, 2019
First Posted (Actual)
February 12, 2019
Study Record Updates
Last Update Posted (Actual)
February 26, 2020
Last Update Submitted That Met QC Criteria
February 24, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-5225
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
IPD data will be shared de-identified as a GUID with the cdRNS data base.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Disturbance
-
Università degli Studi di BresciaCompletedSleep Phase Rhythm DisturbanceItaly
-
The First Affiliated Hospital of Xiamen UniversityNot yet recruitingPostoperative Sleep Disturbance
-
Our Lady's Hospice and Care ServicesSt Vincent's University Hospital, IrelandEnrolling by invitation
-
Zhuan ZhangNot yet recruitingCircadian Rhythm | Postoperative Sleep DisturbanceChina
-
Riphah International UniversityCompletedSleep Disturbance in AthletesPakistan
-
University of BergenGlamoxCompletedSleep | Sleep Deprivation | Shift-Work Related Sleep DisturbanceNorway
-
Sam Houston State UniversityThe University of Texas Health Science Center, Houston; Memorial Hermann Texas...CompletedSleep Disturbance in Hospitalized Antepartum PatientsUnited States
-
Pacific UniversityCompletedInsomnia | Shift-Work Related Sleep DisturbanceUnited States
-
Seoul National University HospitalNot yet recruiting
-
University of North Carolina, Chapel HillWinclove Probiotics B.V.; National Strength and Conditioning Association FoundationCompletedHealthy | Shift-Work Related Sleep DisturbanceUnited States
Clinical Trials on Personal Sleep Monitoring
-
Changsha Tsingray Technology Co., Ltd.RecruitingSleep Breathing DisordersChina
-
Cappadocia UniversityCompleted
-
Massachusetts General HospitalCompletedDepression | Major Depressive DisorderUnited States
-
GLSMED Learning Health S.A.Recruiting
-
University of BernCompleted
-
Hospices Civils de LyonRecruitingIdiopathic Hypersomnia | Narcolepsy Type 1France
-
University of PittsburghEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedSleep DisturbanceUnited States
-
Christopher PattersonCompletedPostoperative Complications | Delirium | Sleep | Hip FracturesCanada
-
Erzincan UniversityCompletedQuality of Life | Nursing Caries | Breastfeeding | Postpartum | Nursing Model | Levine Conservation Model